Literature DB >> 9466447

Adrenal steroids and N-methyl-D-aspartate receptor activation regulate neurogenesis in the dentate gyrus of adult rats through a common pathway.

H A Cameron1, P Tanapat, E Gould.   

Abstract

Adrenal steroids and N-methyl-D-aspartate receptor activation have both been shown to regulate the rate of proliferation of granule neuron progenitor cells in the dentate gyrus of adult rats [Cameron H. A. and Gould E. (1994) Neuroscience 61, 203-209; Cameron H. A. et al. (1995) J. Neurosci. 15, 46874692]. Parallels between the actions of these two factors suggest that they may regulate cell division through a common pathway. This hypothesis was tested by altering both of the factors simultaneously and determining whether the effects were additive. The results of this study demonstrate that alterations in N-methyl-D-aspartate receptor activation block the effects of corticosterone level on cell proliferation; N-methyl-D-aspartate blocks the adrenalectomy-induced increase in [3H]thymidine-labelled cell density in the dentate gyrus, whereas the N-methyl-D-aspartate receptor antagonist dizocilpine maleate (MK-801) prevents the corticosterone-induced decrease in proliferating cells. This finding suggests that adrenal steroids and N-methyl-D-aspartate receptor activation regulate granule cell production in the adult rat dentate gyrus through a common pathway and that N-methyl-D-aspartate receptor activation operates downstream of corticosterone in this pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466447     DOI: 10.1016/s0306-4522(97)00303-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  64 in total

1.  Unique expression patterns of cell fate molecules delineate sequential stages of dentate gyrus development.

Authors:  S J Pleasure; A E Collins; D H Lowenstein
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Strain differences in the effects of chronic corticosterone exposure in the hippocampus.

Authors:  G E Hodes; B R Brookshire; T E Hill-Smith; S L Teegarden; O Berton; I Lucki
Journal:  Neuroscience       Date:  2012-06-23       Impact factor: 3.590

3.  Chronic corticosterone exposure alters postsynaptic protein levels of PSD-95, NR1, and synaptopodin in the mouse brain.

Authors:  Julia W Cohen; Natalia Louneva; Li-Ying Han; Georgia E Hodes; Robert S Wilson; David A Bennett; Irwin Lucki; Steven E Arnold
Journal:  Synapse       Date:  2011-04-11       Impact factor: 2.562

Review 4.  Brain plasticity and antidepressant treatments: new cells, new connections.

Authors:  Ian C Reid; Caroline A Stewart
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

5.  Experience-driven brain plasticity: beyond the synapse.

Authors:  Julie A Markham; William T Greenough
Journal:  Neuron Glia Biol       Date:  2004-11

Review 6.  Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators.

Authors:  Bruce S McEwen
Journal:  Eur J Pharmacol       Date:  2008-01-30       Impact factor: 4.432

Review 7.  Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology.

Authors:  Darrick T Balu; Irwin Lucki
Journal:  Neurosci Biobehav Rev       Date:  2008-08-19       Impact factor: 8.989

8.  Neural stem cells and the regulation of neurogenesis in the adult hippocampus.

Authors:  Bettina Seri; Arturo Alvarez-Buylla
Journal:  Clin Neurosci Res       Date:  2002-05

Review 9.  Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.

Authors:  Evelin L Schaeffer; Orestes V Forlenza; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

10.  Effect of voluntary running on adult hippocampal neurogenesis in cholinergic lesioned mice.

Authors:  New Fei Ho; Siew Ping Han; Gavin S Dawe
Journal:  BMC Neurosci       Date:  2009-06-05       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.